MOLECULAR PARTNERS AG -ADR (MOLN) Forecast, Price Target & Analyst Ratings

NASDAQ:MOLNUS60853G1067

Current stock price

4.6899 USD
+0.14 (+3.19%)
At close:
4.75 USD
+0.06 (+1.28%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MOLECULAR PARTNERS AG -ADR (MOLN).

Forecast Snapshot

Consensus Price Target

Price Target
$12.25
+ 161.31% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A

ChartMill Buy Consensus

Rating
82.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$12.25
Upside
+ 161.31%
From current price of $4.69 to mean target of $12.25, Based on 10 analyst forecasts
Low
$6.50
Median
$10.50
High
$20.27

Price Target Revisions

1 Month
0.00%
3 Months
-7.81%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for MOLN. The average price target is 12.26 USD. This implies a price increase of 161.31% is expected in the next year compared to the current price of 4.6899.
The average price target has been revised downward by 7.81% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

MOLN Current Analyst RatingMOLN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

MOLN Historical Analyst RatingsMOLN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.00%
MOLN was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MOLN.
In the previous month the buy percentage consensus was at a similar level.
MOLN was analyzed by 10 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-27HC Wainwright & Co.Initiate Buy
2025-12-08JP MorganMaintains Neutral -> Neutral
2025-09-03JP MorganMaintains Neutral -> Neutral
2025-03-11LifeSci CapitalInitiate Outperform
2023-12-05JP MorganMaintains Neutral -> Neutral
2022-08-29SVB LeerinkDowngrade Outperform -> Market Perform
2022-05-25Credit SuisseUpgrade Underperform -> Neutral
2022-04-27SVB LeerinkMaintains Outperform
2022-01-14SVB LeerinkMaintains Outperform
2021-08-27SVB LeerinkMaintains Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MOLN revenue by date.MOLN revenue by date.
189.6M
1,843.82%
7.038M
-96.29%
4.97M
-29.38%
1.785M
-64.08%
6.885M
285.71%
28.815M
318.52%
51.329M
78.13%
69.875M
36.13%
124.63M
78.36%
210.67M
69.04%
333.73M
58.41%
445.33M
33.44%
EBITDA
YoY % growth
MOLN ebitda by date.MOLN ebitda by date.
119.001M
295.55%
-58.688M
-149.32%
-58.848M
-0.27%
-55.947M
4.93%
-43.656M
21.97%
-8.619M
80.26%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MOLN ebit by date.MOLN ebit by date.
116.613M
283.88%
-61.108M
-152.40%
-61.217M
-0.18%
-58.778M
3.99%
-60.894M
-3.60%
-49.419M
18.84%
-129.914M
-162.88%
-93.631M
27.93%
-78.587M
16.07%
-32.068M
59.19%
73.242M
328.39%
169.45M
131.36%
Operating Margin
MOLN operating margin by date.MOLN operating margin by date.
61.50%-868.26%-1,231.73%-3,292.86%-884.44%-171.50%-253.10%-134.00%-63.06%-15.22%21.95%38.05%
EPS
YoY % growth
MOLN eps by date.MOLN eps by date.
N/A
266.17%
N/A
-159.60%
N/A
17.79%
-1.49
6.91%
-1.45
2.62%
-0.44
69.73%
-3.00
-582.16%
-1.90
36.78%
-1.33
30.00%
-0.47
64.28%
1.42
399.98%
3.08
116.67%

All data in CHF

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CHF

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MOLN Yearly Revenue VS EstimatesMOLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
MOLN Yearly EPS VS EstimatesMOLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
19.94%
EPS Next 5 Year
-3.42%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
91.86%
Revenue Next 5 Year
76.50%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
23.24%
EBIT Next 5 Year
N/A

MOLECULAR PARTNERS AG -ADR / MOLN Forecast FAQ

What is the average price target for MOLECULAR PARTNERS AG -ADR (MOLN) stock?

10 analysts have analysed MOLN and the average price target is 12.26 USD. This implies a price increase of 161.31% is expected in the next year compared to the current price of 4.6899.

Can you provide the expected long term growth rate for MOLECULAR PARTNERS AG -ADR stock?

The expected long term growth rate for MOLECULAR PARTNERS AG -ADR (MOLN) is 91.86%.